AIM2 and breast cancer: In 2021, Li et al. found that dihydroartemisinin induced pyroptosis in two human breast cancer cell lines (MCF-7 and MDA-MB-231) and reduced the expression of melanoma 2 (AIM2), caspase-3, and gasdermin E (DFNA5).